The DOI matches its Crossref record; 251 of the 251 references it cites were found in a registry or an index.
American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Treatment of Tuberculosis
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.4.16141 · Cited by 1,525
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.supplement_3.ats600 · Cited by 1,241
Bass, J. B., Farer, L. S., Hopewell, P. C., O'Brien, R., Jacobs, R. F., Ruben, F., Snider, D. E., & Thornton, G. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.149.5.8173779 · Cited by 1,193
A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis
Stover, C. K., Warrener, P., VanDevanter, D. R., Sherman, D. R., Arain, T. M., Langhorne, M. H., Anderson, S. W., Towell, J. A., Yuan, Y., McMurray, D. N., et al. (2000) · Nature · doi:10.1038/35016103 · Cited by 1,034
Streptomycin Treatment of Pulmonary Tuberculosis: A Medical Research Council Investigation
(1948) · BMJ · doi:10.1136/bmj.2.4582.769 · Cited by 986
The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin
Greiner, B., Eichelbaum, M., Fritz, P., Kreichgauer, H.-P., von Richter, O., Zundler, J., & Kroemer, H. K. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6663 · Cited by 917
Yeni, P. G., Hammer, S. M., Carpenter, C. C. J., Cooper, D. A., Fischl, M. A., Gatell, J. M., Gazzard, B. G., Hirsch, M. S., Jacobsen, D. M., Katzenstein, D. A., et al. (2002) · JAMA · doi:10.1001/jama.288.2.222 · Cited by 709
Treatment of 171 Patients with Pulmonary Tuberculosis Resistant to Isoniazid and Rifampin
Goble, M., Iseman, M. D., Madsen, L. A., Waite, D., Ackerson, L., & Horsburgh, C. R. (1993) · New England Journal of Medicine · doi:10.1056/nejm199302253280802 · Cited by 698
Global Trends in Resistance to Antituberculosis Drugs
Espinal, M. A., Laszlo, A., Simonsen, L., Boulahbal, F., Kim, S. J., Reniero, A., Hoffner, S., Rieder, H. L., Binkin, N., Dye, C., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104263441706 · Cited by 671
Exogenous Reinfection as a Cause of Recurrent Tuberculosis after Curative Treatment
van Rie, A., Warren, R., Richardson, M., Victor, T. C., Gie, R. P., Enarson, D. A., Beyers, N., & van Helden, P. D. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910143411602 · Cited by 610
Paradoxical Worsening of Tuberculosis Following Antiretroviral Therapy in Patients with AIDS
NARITA, M., ASHKIN, D., HOLLENDER, E. S., & PITCHENIK, A. E. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.1.9712001 · Cited by 608
The Effect of Directly Observed Therapy on the Rates of Drug Resistance and Relapse in Tuberculosis
Weis, S. E., Slocum, P. C., Blais, F. X., King, B., Nunn, M., Matney, G. B., Gomez, E., & Foresman, B. H. (1994) · New England Journal of Medicine · doi:10.1056/nejm199404283301702 · Cited by 589
Iuat (1982) · Bulletin of the World Health Organization · Cited by 515
Espinal, M. A., Kim, S. J., Suarez, P. G., Kam, K. M., Khomenko, A. G., Migliori, G. B., Baéz, J., Kochi, A., Dye, C., & Raviglione, M. C. (2000) · JAMA · doi:10.1001/jama.283.19.2537 · Cited by 507
Isoniazid Liver Injury: Clinical Spectrum, Pathology, and Probable Pathogenesis
MITCHELL, J. R., ZIMMERMAN, H. J., ISHAK, K. G., THORGEIRSSON, U. P., TIMBRELL, J. A., SNODGRASS, W. R., & NELSON, S. D. (1976) · Annals of Internal Medicine · doi:10.7326/0003-4819-84-2-181 · Cited by 505
Community-Based Therapy for Multidrug-Resistant Tuberculosis in Lima, Peru
Mitnick, C., Bayona, J., Palacios, E., Shin, S., Furin, J., Alcántara, F., Sánchez, E., Sarria, M., Becerra, M., Fawzi, M. C. S., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022928 · Cited by 489
The early bactericidal activity of drugs in patients with pulmonary tuberculosis.
Jindani, A., Aber, V. R., Edwards, E. A., & Mitchison, D. A. (1980) · PubMed · doi:10.1164/arrd.1980.121.6.939 · Cited by 487
Treatment of Tuberculosis in Patients with Advanced Human Immunodeficiency Virus Infection
Small, P. M., Schecter, G. F., Goodman, P. C., Sande, M. A., Chaisson, R. E., & Hopewell, P. C. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101313240503 · Cited by 477
The Clinical Pharmacokinetics of Levofloxacin
Fish, D. N., & Chow, A. T. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199732020-00002 · Cited by 475
When Tuberculosis Treatment Fails: A Social Behavioral Account of Patient Adherence
Sumartojo, E. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/147.5.1311 · Cited by 468
Toxic Hepatitis with Isoniazid and Rifampin
Steele, M. A., Burk, R. F., & DesPrez, R. M. (1991) · Chest · doi:10.1378/chest.99.2.465 · Cited by 437
Tuberculous Meningitis in Patients Infected with the Human Immunodeficiency Virus
Berenguer, J., Moreno, S., Laguna, F., Vicente, T., Adrados, M., Ortega, A., González-LaHoz, J., & Bouza, E. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203053261004 · Cited by 432
Hepatitis B: Evolving Epidemiology and Implications for Control
Margolis, H., Alter, M., & Hadler, S. (1991) · Seminars in Liver Disease · doi:10.1055/s-2008-1040427 · Cited by 430
Clinical Pharmacokinetics of Rifampicin
Acocella, G. (1978) · Clinical Pharmacokinetics · doi:10.2165/00003088-197803020-00002 · Cited by 405
The resurgence of tuberculosis: is your laboratory ready?
Tenover, F. C., Crawford, J. T., Huebner, R. E., Geiter, L. J., Horsburgh, C. R., & Good, R. C. (1993) · Journal of Clinical Microbiology · doi:10.1128/jcm.31.4.767-770.1993 · Cited by 374
Isoniazid-Associated Hepatitis in 114 Patients
Black, M., Mitchell, J. R., Zimmerman, H. J., Ishak, K. G., & Epler, G. R. (1975) · Gastroenterology · doi:10.1016/s0016-5085(19)32568-5 · Cited by 370
Isoniazid-related hepatitis: a U.S. Public Health Service cooperative surveillance study.
De, K., Snider, D. E., & Caras, G. J. (1978) · PubMed · doi:10.1164/arrd.1978.117.6.991 · Cited by 368
Nolan, C. M., Goldberg, S. V., & Buskin, S. E. (1999) · JAMA · doi:10.1001/jama.281.11.1014 · Cited by 368
Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy
Dean, G. L., Edwards, S. G., Ives, N. J., Matthews, G., Fox, E. F., Navaratne, L., Fisher, M., Taylor, G. P., Miller, R., Taylor, C. B., et al. (2002) · AIDS · doi:10.1097/00002030-200201040-00010 · Cited by 354
Hebert, M. F., Roberts, J. P., Prueksaritanont, T., & Benet, L. Z. (1992) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1992.171 · Cited by 337
The United States Public Health Service, 1798–1950
Williams, R. C. (1952) · AJN, American Journal of Nursing · doi:10.1097/00000446-195210000-00069 · Cited by 335
Role of individual drugs in the chemotherapy of tuberculosis.
Mitchison, D. A. (2000) · PubMed · Cited by 319
David, H. L. (1970) · Applied Microbiology · doi:10.1128/aem.20.5.810-814.1970 · Cited by 317
Treatment of multidrug-resistant pulmonary tuberculosis with interferon-γ via aerosol
Condos, R., Rom, W. N., & Schluger, N. W. (1997) · The Lancet · doi:10.1016/s0140-6736(96)12273-x · Cited by 316
Combs, D. L., O'Brien, R. J., & Geiter, L. J. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-76-3-112-6-397 · Cited by 315
The Nephrotoxicity of Antimicrobial Agents
Appel, G. B., & Neu, H. C. (1977) · New England Journal of Medicine · doi:10.1056/nejm197703312961305 · Cited by 310
Vernon, A., Burman, W., Benator, D., Khan, A., & Bozeman, L. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11467-8 · Cited by 308
Shafran, S. D., Singer, J., Zarowny, D. P., Phillips, P., Salit, I., Walmsley, S. L., Fong, I. W., Gill, M. J., Rachlis, A. R., Lalonde, R. G., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608083350602 · Cited by 307
Hong Kong Chest Service/Tuberculosis Research Centre, M. M. R. C. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/145.1.36 · Cited by 304
Frieden, T. R. (1996) · JAMA · doi:10.1001/jama.276.15.1229 · Cited by 295
UNGO, J. R., JONES, D., ASHKIN, D., HOLLENDER, E. S., BERNSTEIN, D., ALBANESE, A. P., & PITCHENIK, A. E. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.6.9711039 · Cited by 292
Mitchison, D. A., & Nunn, A. (1986) · PubMed · doi:10.1164/arrd.1986.133.3.423 · Cited by 291
Randomised controlled trial of self-supervised and directly observed treatment of tuberculosis
Zwarenstein, M., Schoeman, J. H., Vundule, C., Lombard, C. J., & Tatley, M. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04022-7 · Cited by 281
Neurological aspects of tropical disease: Tuberculous meningitis
Thwaites, G. (2000) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.68.3.289 · Cited by 274
Yuan, R., Flockhart, D. A., & Balian, J. D. (1999) · The Journal of Clinical Pharmacology · doi:10.1177/009127009903901102 · Cited by 271
Worldwide Incidence of Multidrug‐Resistant Tuberculosis
Dye, C., Espinal, M. A., Watt, C. J., Mbiaga, C., & Williams, B. G. (2002) · The Journal of Infectious Diseases · doi:10.1086/339818 · Cited by 269
How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults?
Moulding, T. (2000) · PubMed · Cited by 268
Maldhure, B. R., Munje, R. P., Zodpey, S. P., et al. (1997) · Lung India · Cited by 260
Adjunctive Corticosteroid Therapy for Tuberculosis: A Critical Reappraisal of the Literature
Dooley, D. P., Carpenter, J. L., & Rademacher, S. (1997) · Clinical Infectious Diseases · doi:10.1086/515543 · Cited by 259
Singh, M. M., Bhargava, A. N., & Jain, K. P. (1969) · New England Journal of Medicine · doi:10.1056/nejm196911132812003 · Cited by 246
Activities of Several Novel Oxazolidinones against Mycobacterium tuberculosis in a Murine Model
Cynamon, M. H., Klemens, S. P., Sharpe, C. A., & Chase, S. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1189 · Cited by 243
Perriëns, J. H., St. Louis, M. E., Mukadi, Y. B., Brown, C., Prignot, J., Pouthier, F., Portaels, F., Willame, J.-C., Mandala, J. K., Kaboto, M., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503233321204 · Cited by 232
Cohn, D. L., Catlin, B. J., Peterson, K. L., Judson, F. N., & Sbarbaro, J. A. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-76-3-112-6-407 · Cited by 232
Walley, J. D., Khan, M. A., Newell, J. N., & Khan, M. H. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04129-5 · Cited by 230
Rifampicin reduces effectiveness and bioavailability of prednisolone.
McAllister, W. A., Thompson, P. J., Al-Habet, S. M., & Rogers, H. J. (1983) · BMJ · doi:10.1136/bmj.286.6369.923 · Cited by 227
Strang, J. I. G., Gibson, D. G., Mitchison, D. A., Girling, D. J., Kakaza, H. H. S., Allen, B. W., Evans, D. J., Nunn, A. J., & Fox, W. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92415-4 · Cited by 227
Purpose of Quality Standards for Infectious Diseases
Gross, P. A., Barrett, T. L., Dellinger, E. P., Krause, P. J., Martone, W. J., McGowan, J. E., Sweet, R. L., & Wenzel, R. P. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.3.421 · Cited by 223
The Need for New Drugs against Tuberculosis
O'BRIEN, R. J., & NUNN, P. P. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.5.2007122 · Cited by 221
Simon, H. B., Weinstein, A. J., Pasternak, M. S., Swartz, M. N., & Kunz, L. J. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90279-0 · Cited by 219
Mahmoudi, A. (1993) · JAMA · doi:10.1001/jama.270.1.65 · Cited by 219
Strang, J. I. G., Gibson, D. G., Nunn, A. J., Kakaza, H. H. S., Girling, D. J., & Fox, W. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91127-5 · Cited by 218
Dexamethasone adjunctive treatment for tuberculous meningitis
GIRGIS, N. I., FARID, Z., KILPATRICK, M. E., SULTAN, Y., & MIKHAIL, I. A. (1991) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199103000-00002 · Cited by 217
Eleven Years of Community-Based Directly Observed Therapy for Tuberculosis
Chaulk, C. P. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530120037038 · Cited by 217
GENITOURINARY TUBERCULOSIS: REVIEW OF 102 CASES
CHRISTENSEN, W. I. (1974) · Medicine · doi:10.1097/00005792-197409000-00004 · Cited by 216
Assessment of New Sterilizing Drugs for Treating Pulmonary Tuberculosis by Culture at 2 Months
Mitchison, D. A. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/147.4.1062 · Cited by 215
Rifampin-Induced Methadone Withdrawal
Kreek, M. J., Garfield, J. W., Gutjahr, C. L., & Giusti, L. M. (1976) · New England Journal of Medicine · doi:10.1056/nejm197605132942008 · Cited by 215
Treatment of HIV-related Tuberculosis in the Era of Effective Antiretroviral Therapy
BURMAN, W. J., & JONES, B. E. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.1.2101133 · Cited by 214
Potentially Serious Side Effects of High-dose Twice-weekly Rifampicin
Poole, G., Stradling, P., & Worlledge, S. (1971) · BMJ · doi:10.1136/bmj.3.5770.343 · Cited by 209
Karyadi, E., West, C. E., Schultink, W., Nelwan, R. H., Gross, R., Amin, Z., Dolmans, W. M., Schlebusch, H., & van der Meer, J. W. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/75.4.720 · Cited by 209
Clinical Pharmacokinetics of Isoniazid
Weber, W. W., & Hein, D. W. (1979) · Clinical Pharmacokinetics · doi:10.2165/00003088-197904060-00001 · Cited by 207
Sharma, R., Saxena, D., Dwivedi, A. K., & Misra, A. (2001) · Pharmaceutical Research · doi:10.1023/a:1012296604685 · Cited by 201
Jasmer, R. M., Saukkonen, J. J., Blumberg, H. M., Daley, C. L., Bernardo, J., Vittinghoff, E., King, M. D., Kawamura, L. M., Hopewell, P. C., & for the Short-Course Rifampin and Pyrazinamide for Tuberculosis Infection (SCRIPT) Study Investigators* (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-8-200210150-00007 · Cited by 201
Isoniazid-associated Hepatitis Deaths: A Review of Available Information
Snider, D. E., & Caras, G. J. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/145.2_pt_1.494 · Cited by 199
Frieden, T. R. (1996) · JAMA · doi:10.1001/jama.1996.03540150031027 · Cited by 199
Lymph node tuberculosis: A comparison of various methods of treatment
Campbell, I. A., & Dyson, A. J. (1977) · Tubercle · doi:10.1016/0041-3879(77)90041-1 · Cited by 189
Effects of aluminum and magnesium antacids and ranitidine on the absorption of ciprofloxacin
Nix, D. E., Watson, W. A., Lener, M. E., Frost, R. W., Krol, G., Goldstein, H., Lettieri, J., & Schentag, J. J. (1989) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1989.207 · Cited by 186
Noncompliance With Directly Observed Therapy for Tuberculosis
Burman, W. J., Cohn, D. L., Rietmeijer, C. A., Judson, F. N., Reves, R. R., & Sbarbaro, J. A. (1997) · Chest · doi:10.1378/chest.111.5.1168 · Cited by 185
Adverse Effects of Antituberculosis Drugs
Girling, D. J. (1982) · Drugs · doi:10.2165/00003495-198223010-00003 · Cited by 182
Wallace, R. J., Brown, B. A., Griffith, D. E., Girard, W., & Tanaka, K. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.3.747 · Cited by 181
The nifedipine-rifampin interaction. Evidence for induction of gut wall metabolism.
Holtbecker, N., Fromm, M. F., Kroemer, H. K., Ohnhaus, E. E., & Heidemann, H. (1996) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08415-6 · Cited by 178
Barman Balfour, J. A., & Wiseman, L. R. (1999) · Drugs · doi:10.2165/00003495-199957030-00007 · Cited by 174
Li, A. P., Reith, M. K., Rasmussen, A., Gorski, J. C., Hall, S. D., Xu, L., Kaminski, D. L., & Cheng, L. K. (1997) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(97)00071-9 · Cited by 172
Low Serum Antimycobacterial Drug Levels in Non-HIV-Infected Tuberculosis Patients
Kimerling, M. E., Phillips, P., Patterson, P., Hall, M., Robinson, C. A., & Dunlap, N. E. (1998) · Chest · doi:10.1378/chest.113.5.1178 · Cited by 170
Hakim, J. G., Ternouth, I., Mushangi, E., Siziya, S., Robertson, V, & Malin, A. (2000) · Heart · doi:10.1136/heart.84.2.183 · Cited by 169
Treatment of Tuberculosis during Pregnancy
Snider, D. E., Layde, P. M., Johnson, M. W., & Lyle, M. A. (1981) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198103000-00007 · Cited by 168
Tuberculous meningitis in patients with and without human immunodeficiency virus infection
Dubé, M. P., Holtom, P. D., & Larsen, R. A. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90579-z · Cited by 168
Pulmonary resection for multi–drug resistant tuberculosis
Pomerantz, B. J., Cleveland, J. C., Olson, H. K., & Pomerantz, M. (2001) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1067/mtc.2001.112339 · Cited by 164
Clinical Pharmacokinetics of Fluvastatin
Scripture, C. D., & Pieper, J. A. (2001) · Clinical Pharmacokinetics · doi:10.2165/00003088-200140040-00003 · Cited by 163
Rifampin greatly reduces plasma simvastatin and simvastatin acid concentrations
Kyrklund, C. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.111414 · Cited by 163
Hong Kong Chest Service/British Medical Research Council (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/143.4_pt_1.700 · Cited by 163
Perriëns, J. H., Colebunders, R. L., Karahunga, C., Willame, J.-C., Jeugmans, J., Kaboto, M., Mukadi, Y., Pauwels, P., Ryder, R. W., Prignot, J., et al. (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/144.4.750 · Cited by 162
EFFECTS OF ISONIAZID ON PYRIDOXINE METABOLISM
Biehl, J. P. (1954) · Journal of the American Medical Association · doi:10.1001/jama.1954.02950170003002 · Cited by 160
Trends in Drug-Resistant Tuberculosis in the United States, 1993-1996
Moore, M. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550100059039 · Cited by 159
Griffith, D. E., Brown, B. A., Girard, W. M., & Wallace, R. J. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.3.594 · Cited by 159
Frequency and type of reactions to antituberculosis drugs: Observations in routine treatment
Ormerod, L. P., & Horsfield, N. (1996) · Tubercle and Lung Disease · doi:10.1016/s0962-8479(96)90073-8 · Cited by 158
MURRAY, J., SONNENBERG, P., SHEARER, S. C., & GODFREY-FAUSSETT, P. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.3.9804147 · Cited by 158
Low Antituberculosis Drug Concentrations in Patients with AIDS
Peloquin, C. A., Nitta, A. T., Burman, W. J., Brudney, K. F., Miranda-Massari, J. R., McGuinness, M. E., Berning, S. E., & Gerena, G. T. (1996) · Annals of Pharmacotherapy · doi:10.1177/106002809603000901 · Cited by 158
Paradoxical Worsening of Tuberculosis in HIV-Infected Persons
Wendel, K. A., Alwood, K. S., Gachuhi, R., Chaisson, R. E., Bishai, W. R., & Sterling, T. R. (2001) · Chest · doi:10.1378/chest.120.1.193 · Cited by 157
Self-citationLiver injury during antituberculosis treatment: An 11-year study
Døssing, M., Wilcke, J. T., Askgaard, D. S., & Nybo, B. (1996) · Tubercle and Lung Disease · doi:10.1016/s0962-8479(96)90098-2 · Cited by 157
Corticosteroids in the Treatment of Tuberculous Pleurisy
Lee, C.-H., Wang, W.-J., Rs, L., Tsai, Y., & Chiang, Y.-C. (1988) · CHEST Journal · doi:10.1378/chest.94.6.1256 · Cited by 155
Tuberculous meningitis in South African urban adults
Karstaedt, A. (1998) · QJM · doi:10.1093/qjmed/91.11.743 · Cited by 153
Susceptibility Testing for Mycobacteria
Reller, L. B., Weinstein, M. P., & Woods, G. L. (2000) · Clinical Infectious Diseases · doi:10.1086/317441 · Cited by 152
Burman, W. J., Gallicano, K., & Peloquin, C. A. (1999) · Clinical Infectious Diseases · doi:10.1086/515174 · Cited by 152
Short-Course Chemotherapy for Extrapulmonary Tuberculosis
Dutt, A. K., MOERS, D., & STEAD, W. W. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-104-1-7 · Cited by 143
Tuberculous peritonitis – reports of 26 cases, detailing diagnostic and therapeutic problems
Demir, K., Ökten, A., Kaymakoğlu, S., et al. (2001) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200105000-00019 · Cited by 140
Moss, A. R., Hahn, J. A., Tulsky, J. P., Daley, C. L., Small, P. M., & Hopewell, P. C. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.2.9910055 · Cited by 139
The Clinical Pharmacokinetics of Rifabutin
Blaschke, T. F., & Skinner, M. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.supplement_1.s15 · Cited by 138
Adverse reactions to rifampicin in antituberculosis regimens
Girling, D. J. (1977) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/3.2.115 · Cited by 135
Martínez, E., Collazos, J., & Mayo, J. (1999) · Medicine · doi:10.1097/00005792-199911000-00001 · Cited by 135
Increased recurrence of tuberculosis in HIV-1-infected patients in Kenya
Hawken, M. P., Nunn, P., Godfrey‐Faussett, P., et al. (1993) · The Lancet · doi:10.1016/0140-6736(93)91474-z · Cited by 132
Practice Guidelines for the Treatment of Tuberculosis
Horsburgh, C. R., Feldman, S., & Ridzon, R. (2000) · Clinical Infectious Diseases · doi:10.1086/314007 · Cited by 131
Girgis, N. I., Sultan, Y., Farid, Z., Mansour, M. M., Erian, M. W., Hanna, L. S., & Mateczun, A. J. (1998) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1998.58.28 · Cited by 131
The Use of Legal Action in New York City to Ensure Treatment of Tuberculosis
Gasner, M. R., Maw, K. L., Feldman, G. E., Fujiwara, P. I., & Frieden, T. R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902043400506 · Cited by 130
Darbyshire, J. H. (1999) · International Orthopaedics · doi:10.1007/s002640050311 · Cited by 128
Uveitis and Pseudojaundice During a Regimen of Clarithromycin, Rifabutin, and Ethambutol
Shafran, S. D., Deschênes, J., Miller, M. J., Phillips, P., & Toma, E. (1994) · New England Journal of Medicine · doi:10.1056/nejm199402103300616 · Cited by 126
Hong Kong Chest Service/British Medical Research Council (1987) · American Review of Respiratory Disease · doi:10.1164/ajrccm/136.6.1339 · Cited by 126
Clinical Consequences and Transmissibility of Drug-Resistant Tuberculosis in Southern Mexico
García-García, M. D. L., Ponce‐de‐León, A., Jiménez-Corona, M. E., Jiménez-Corona, A., Palacios-Martínez, M., Balandrano, S., Ferreyra-Reyes, L. D., Juárez-Sandino, L., Sifuentes‐Osornio, J., Olivera-Díaz, H., et al. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.5.630 · Cited by 125
Dexamethasone in Tuberculous Meningitis
O'Toole, R. D., THORNTON, G. F., MUKHERJEE, M. K., & NATH, R. L. (1969) · Annals of Internal Medicine · doi:10.7326/0003-4819-70-1-39 · Cited by 124
Hsu, K. H. K. (1984) · JAMA · doi:10.1001/jama.1984.03340340023018 · Cited by 124
Black, R. E., Lau, W. K. K., Weinstein, R. J., Young, L. S., & Hewitt, W. L. (1976) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.9.6.956 · Cited by 124
Dickinson, J. M., & Mitchison, D. A. (1981) · PubMed · doi:10.1164/arrd.1981.123.4.367 · Cited by 123
Bodmer, T., Zürcher, G., Imboden, P., et al. (1995) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/35.2.345 · Cited by 123
Chaisson, R. E., Clermont, H. C., Holt, E., et al. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.4.8887603 · Cited by 122
DesJardin, L. E., Perkins, M. D., Wolski, K., Haun, S., Teixeira, L., Chen, Y., Johnson, J. L., Ellner, J. J., Dietze, R., Bates, J. H., et al. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.1.9811006 · Cited by 122
Kamolratanakul, P., Sawert, H., Lertmaharit, S., Kasetjaroen, Y., Akksilp, S., Tulaporn, C., Punnachest, K., Na-Songkhla, S., & Payanandana, V. (1999) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(99)90379-6 · Cited by 120
The Role of Pyrazinamide in Tuberculosis Chemotherapy
Steele, M. A., & Prez, R. M. D. (1988) · CHEST Journal · doi:10.1378/chest.94.4.845 · Cited by 120
El-Sadr, W. M., Perlman, D. C., Matts, J. P., Nelson, E. T., Cohn, D. L., Salomon, N., Olibrice, M., Medard, F., Chirgwin, K. D., Mildvan, D., et al. (1998) · Clinical Infectious Diseases · doi:10.1086/520275 · Cited by 119
Zilly, W., Breimer, D. D., & Richter, E. A. (1975) · European Journal of Clinical Pharmacology · doi:10.1007/bf00614021 · Cited by 116
Rifampin decreases the plasma concentrations and effects of repaglinide
Niemi, M. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.111183 · Cited by 115
Gonzalez-Montaner, L. J., Natal, S., Yongchaiyud, P., et al. (1994) · Tubercle and Lung Disease · doi:10.1016/0962-8479(94)90079-5 · Cited by 113
Crump, J. A., Tyrer, M., Lloyd‐Owen, S. J., Han, L. Y., Lipman, M. C. I., & Johnson, M. A. (1998) · Clinical Infectious Diseases · doi:10.1086/517636 · Cited by 113
Mortality From Tuberculous Meningitis Reduced by Steroid Therapy
Escobar, J. A. D., Belsey, M. A., Duenas, A. P., & Medina, P. (1975) · PEDIATRICS · doi:10.1542/peds.56.6.1050 · Cited by 112
Barditch‐Crovo, P., Trapnell, C. B., Ette, E., Zacur, H. A., Coresh, J., ROCCO, L., HENDRIX, C., & Flexner, C. W. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)70138-4 · Cited by 111
Sidibé, K., Sassan‐Morokro, M., Ackah, A., et al. (1995) · AIDS · doi:10.1097/00002030-199510000-00011 · Cited by 111
Should Women Taking Antituberculosis Drugs Breast-feed?
Snider, D. E., & Powell, K. R. (1984) · Archives of Internal Medicine · doi:10.1001/archinte.1984.00350150199040 · Cited by 111
Ciprofloxacin increases serum levels of theophylline.
Raoof, S., Wollschlager, C. M., & Khan, F. A. (1987) · PubMed · Cited by 109
Corticosteroids in the Treatment of Tuberculous Pleurisy
Wyser, C. P., Walzl, G., Smedema, J., Swart, F., van Schalkwyk, E. M., & de Wal, B. W. V. (1996) · CHEST Journal · doi:10.1378/chest.110.2.333 · Cited by 109
Park, S. K., Kim, C. T., & Song, S. D. (1998) · PubMed · Cited by 108
USING THERAPEUTIC DRUG MONITORING TO DOSE THE ANTIMYCOBACTERIAL DRUGS
Peloquin, C. A. (1997) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(05)70357-9 · Cited by 107
Okwera, A., Byekwaso, F., Mugerwa, M., Okwera, A., Byekwaso, F., Ellner, J. J., Vjecha, M. J., Johnson, J. L., Whalen, C., & Huebner, R. E. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90693-9 · Cited by 107
Kyriazopoulou, V. E., PARPAROUSI, O., & Vagenakis, A. G. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-6-1204 · Cited by 105
Controlling the Resurgent Tuberculosis Epidemic
Gostin, L. O. (1993) · JAMA · doi:10.1001/jama.1993.03500020089038 · Cited by 105
Paradoxical Reactions in HIV and Pulmonary TB
Chien, J. W., & Johnson, J. L. (1998) · CHEST Journal · doi:10.1378/chest.114.3.933 · Cited by 102
McGregor, M. M., Olliaro, P., Wolmarans, L., Mabuza, B., Bredell, M., Felten, M. K., & Fourie, P. B. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.5.8912765 · Cited by 101
Severe Acetaminophen Toxicity in a Patient Receiving Isoniazid
Murphy, R., Swartz, R. H., & Watkins, P. B. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-10-799 · Cited by 98
Renal Allograft Dysfunction Associated with Rifampin–Tacrolimus Interaction
Chenhsu, R.-Y., Loong, C., Chou, M.-H., Lin, M.-F., & Yang, W. (2000) · Annals of Pharmacotherapy · doi:10.1345/aph.19069 · Cited by 96
Lötte, A., Hatton, F., Perdrizet, S., & Rouillon, A. (1964) · PubMed Central · Cited by 94
Intensive short course chemotherapy in the management of tuberculous meningitis.
Donald, P. R., Schoeman, J. F., Zyl, L. E. V., de Villiers, J. N., Pretorius, M., & Springer, P. E. (1998) · PubMed · Cited by 94
Possible implications of doxycycline-rifampin interaction for treatment of brucellosis
Colmenero, J. D., Fernández-Gallardo, L. C., Agúndez, J. A. G., et al. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.12.2798 · Cited by 93
Absorption, metabolism and excretion of pyrazinamide in man
Ellard, G. A. (1969) · Tubercle · doi:10.1016/0041-3879(69)90020-8 · Cited by 90
Perucca, E., Grimaldi, R., Frigo, G. M., Sardi, A., M�nig, H., & Ohnhaus, E. E. (1988) · European Journal of Clinical Pharmacology · doi:10.1007/bf00615223 · Cited by 89
Clinical Importance of the Interaction of Phenytoin and Isoniazid
Miller, R. R., Porter, J., & Greenblatt, D. J. (1979) · CHEST Journal · doi:10.1378/chest.75.3.356 · Cited by 89
Narita, M., Stambaugh, J. J., Hollender, E. S., Jones, D., Pitchenik, A. E., & Ashkin, D. (2000) · Clinical Infectious Diseases · doi:10.1086/313771 · Cited by 89
Schwander, S., Rüsch–Gerdes, S., Mateega, A., Lutalo, T., Tugume, S. B., Kityo, C. M., Rubaramira, R., Mugyenyi, P. N., Okwera, A., Mugerwa, R. D., et al. (1995) · Tubercle and Lung Disease · doi:10.1016/s0962-8479(05)80007-3 · Cited by 87
Six months versus nine months chemotherapy for tuberculosis of lymph nodes: Final results
Campbell, I. A., Ormerod, L. P., Friend, J. A. R., Jenkins, P. A., & Prescott, R. J. (1993) · Respiratory Medicine · doi:10.1016/s0954-6111(05)80265-3 · Cited by 87
Hafner, R., Bethel, J., Power, M. E., et al. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.3.631 · Cited by 85
Fatal isoniazid-induced hepatitis. Its risk during chemoprophylaxis.
Salpeter, S. R. (1993) · PubMed Central · Cited by 84
Burman, W. J., Dalton, C. B., Cohn, D. L., Butler, J. R. G., & Reves, R. R. (1997) · CHEST Journal · doi:10.1378/chest.112.1.63 · Cited by 83
Ebert, U., Thong, N. Q., Oertel, R., et al. (2000) · European Journal of Clinical Pharmacology · doi:10.1007/s002280000146 · Cited by 83
Isoniazid Drug and Food Interactions
Self, T. H., Chrisman, C. R., Baciewicz, A. M., & Bronze, M. S. (1999) · The American Journal of the Medical Sciences · doi:10.1016/s0002-9629(15)40533-6 · Cited by 82
Intensive short course chemotherapy for tuberculous meningitis
Jacobs, R. F., SUNAKORN, P., CHOTPITAYASUNONAH, T., Pope, S. K., & Kelleher, K. J. (1992) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199203000-00004 · Cited by 81
Tuberculous Meningitis at a Large Inner-City Medical Center
Porkert, M., Sotir, M. J., Parrott-Moore, P., & Blumberg, H. M. (1997) · The American Journal of the Medical Sciences · doi:10.1016/s0002-9629(15)40131-4 · Cited by 80
Cations in the didanosine tablet reduce ciprofloxacin bioavailability
Sahai, J. V., Gallicano, K., Oliveras, L., et al. (1993) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1993.24 · Cited by 80
International Union Against Tuberculosis, Committee of Prophylaxis.
(1969) · PubMed · Cited by 80
Diazepam interaction with antituberculosis drugs
Ochs, H. R., Greenblatt, D. J., Roberts, G.-M., et al. (1981) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1981.94 · Cited by 79
The Effect of Hemodialysis on Isoniazid, Rifampin, Pyrazinamide, and Ethambutol
Malone, R. S., Fish, D. N., Spiegel, D. M., CHILDS, J. M., & Peloquin, C. A. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.5.9810034 · Cited by 76
Yechoor, V. K., Shandera, W. X., Rodriguez, P., & Cate, T. R. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440140144014 · Cited by 75
Fixed-Dose Combinations of Antituberculous Medications To Prevent Drug Resistance
Moulding, T., Dutt, A. K., & Reichman, L. B. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-12-199506150-00010 · Cited by 75
Wallis, R. S., Nsubuga, P., Whalen, C., Mugerwa, R. D., Okwera, A., Oette, D. H., Jackson, J. B., Johnson, J. L., & Ellner, J. J. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/174.4.727 · Cited by 75
Effects of Rifabutin and Rifampicin on the Pharmacokinetics of Ethinylestradiol and Norethindrone
LeBel, M., Masson, E., Guilbert, É., Colborn, D., Paquet, F., Allard, S., Vallée, F., & Narang, P. K. (1998) · The Journal of Clinical Pharmacology · doi:10.1177/009127009803801109 · Cited by 73
Coadministration of Rifampin and Itraconazole Leads to Undetectable Levels of Serum Itraconazole
Drayton, J., Dickinson, G., & Rinaldi, M. G. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.2.266 · Cited by 73
Griffith, D. E., Brown, B. A., Murphy, D. T., Girard, W. M., Couch, L., & Wallace, R. J. (1998) · The Journal of Infectious Diseases · doi:10.1086/515597 · Cited by 72
Effect of rifampicin on the pharmacokinetics of itraconazole in normal volunteers and AIDS patients
Jaruratanasirikul, S., & Sriwiriyajan, S. (1998) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050437 · Cited by 72
Kumar, L., Dhand, R., SINGHI, P. D., RAO, K. L. N., & KATARIYA, S. (1990) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199011000-00004 · Cited by 72
Hepatotoxicity of antituberculosis drugs.
Ormerod, L. P., Skinner, C., & Wales, J. K. (1996) · Thorax · doi:10.1136/thx.51.2.111 · Cited by 72
Smear- and Culture-negative Pulmonary Tuberculosis: Four-month Short-course Chemotherapy
Dutt, A. K., Moers, D., & Stead, W. W. (1989) · American Review of Respiratory Disease · doi:10.1164/ajrccm/139.4.867 · Cited by 71
Carbamazepine intoxication caused by interaction with isoniazid.
Valsalan, V. C., & Cooper, G. L. (1982) · BMJ · doi:10.1136/bmj.285.6337.261 · Cited by 70
Pharmacokinetic Interaction between Amprenavir and Rifabutin or Rifampin in Healthy Males
Polk, R. E., Brophy, D. F., Israel, D. S., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.502-508.2001 · Cited by 70
Dilger, K., Greiner, B., Fromm, M. F., Hofmann, U., Kroemer, H. K., & Eichelbaum, M. F. (1999) · Pharmacogenetics · doi:10.1097/00008571-199910000-00002 · Cited by 69
Hong Kong Chest Service/British Medical Research Council (1982) · Tubercle · doi:10.1016/s0041-3879(82)80044-5 · Cited by 68
Chan, S. L., Yew, W. W., Ma, W. K., et al. (1992) · Tubercle and Lung Disease · doi:10.1016/0962-8479(92)90077-w · Cited by 66
Penetration of pyrazinamide into the cerebrospinal fluid in tuberculous meningitis.
Ellard, G. A., Humphries, M. J., Gabriel, M., & Teoh, R. (1987) · BMJ · doi:10.1136/bmj.294.6567.284 · Cited by 66
Lipid lunch for persistent pathogen
Bishai, W. R. (2000) · Nature · doi:10.1038/35021159 · Cited by 66
Rifampin reduces plasma concentrations and effects of zolpidem*
Villikka, K., Kivistö, K. T., Luurila, H., & Neuvonen, P. J. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90082-5 · Cited by 64
Short course chemotherapy for tuberculous lymphadenitis in children.
Jawahar, M. S., Sivasubramanian, S., Vijayan, V., Ramakrishnan, C. V., Paramasivan, C. N., Selvakumar, V., Paul, S., Tripathy, S. P., & Prabhakar, R. (1990) · BMJ · doi:10.1136/bmj.301.6748.359 · Cited by 63
Service, H. K. C. (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/143.2.262 · Cited by 63
Onwubalili, J. K., Scott, G. M., & Smith, H. (1986) · QJM · doi:10.1093/oxfordjournals.qjmed.a067986 · Cited by 63
Pharmacokinetic study of the interaction between rifampin and delavirdine mesylate*
Borin, M. T., Chambers, J. H., Carel, B. J., Gagnon, S., & Freimuth, W. W. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90134-x · Cited by 62
Effect of sucralfate on absorption of norfloxacin and ofloxacin
Lehto, P., & Kivistö, K. T. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.2.248 · Cited by 61
Effect of rifampicin on the pharmacokinetics and pharmacodynamics of glimepiride
Niemi, M., Kivistö, K. T., Backman, J. T., et al. (2000) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2000.00295.x · Cited by 60
Caraco, Y., Sheller, J. R., & Wood, A. J. J. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36560-7 · Cited by 54
Tam, C. M., Chan, S. L., Kam, K. M., Goodall, R. L., & Mitchison, D. A. (2002) · PubMed · Cited by 54
Induction of propranolol metabolism by rifampicin.
Herman, R., Nakamura, K., Wilkinson, G., et al. (1983) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1983.tb02218.x · Cited by 52
Isoniazid and Reaction to Cheese
SMITH, C. K., & DURACK, D. T. (1978) · Annals of Internal Medicine · doi:10.7326/0003-4819-88-4-520 · Cited by 52
Cited by
Griffith, D. E., Aksamit, T., Brown-Elliott, B. A., Catanzaro, A., Daley, C., Gordin, F., Holland, S. M., Horsburgh, R., Huitt, G., Iademarco, M. F., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200604-571st · Cited by 6,110
Self-citationKornbluth, A., & Sachar, D. B. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.727 · Cited by 2,023
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
Falzon, D., Jaramillo, E., Schünemann, H. J., Arentz, M., Bauer, M., Bayona, J., Blanc, L., Caminero, J. A., Daley, C. L., Duncombe, C., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00073611 · Cited by 1,100
Advances in the development of new tuberculosis drugs and treatment regimens
Zumla, A., Nahid, P., & Cole, S. T. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4001 · Cited by 893
The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis
Diacon, A. H., Pym, A., Grobusch, M., Patientia, R., Rustomjee, R., Page-Shipp, L., Pistorius, C., Krause, R., Bogoshi, M., Churchyard, G., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808427 · Cited by 835
Metadata
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-02-15
- Volume
- 167
- Issue
- 4
- Pages
- 603-662
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2418210342
- Cited by
- 1,944
- References
- 251
- FWCI
- 59.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.